http://ir.ziopharm.com/releases.cfm?sh_auth=0.0.0.ad1dcb691ef81696c0c02ea27e385165Ziopharm Oncology, Inc. - General Releasesen-usShareholder.com RSS Feedhttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=765367Thu, 16 May 2013 04:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=765367ZIOPHARM Announces Presentation of Promising Nonclinical and Phase I Study Results of Ad-RTS-IL-12 in Advanced Melanoma at ASGCT 16th Annual Meetinghttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=765242Wed, 15 May 2013 04:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=765242ZIOPHARM Announces Poster Presentation at the 2013 American Society for Clinical Oncology (ASCO) Annual Meetinghttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=755143Tue, 09 Apr 2013 04:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=755143ZIOPHARM Presents Preclinical Data Supporting DNA-Based IL-12 Therapy for Breast Cancerhttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=750983Tue, 26 Mar 2013 04:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=750983ZIOPHARM Terminates Development of Palifosfamide in Metastatic Soft Tissue Sarcomahttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=746924Mon, 11 Mar 2013 04:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=746924ZIOPHARM Oncology Initiates Phase 2 Study of Ad-RTS IL-12 and Palifosfamide Combination for Treatment of Advanced Breast Cancerhttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=746177Thu, 07 Mar 2013 05:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=746177ZIOPHARM Oncology to Present at the Barclays Global Healthcare Conferencehttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=745578Wed, 06 Mar 2013 05:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=745578ZIOPHARM Oncology Announces Initiation of Indiana University-Sponsored Phase 2 Study of Palifosfamide in Recurrent and Incurable Germ Cell (Testicular and Ovarian) Tumorshttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=739580Tue, 12 Feb 2013 05:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=739580Phase 3 Trial of ZIOPHARM'S Palifosfamide in First-Line Metastatic Soft Tissue Sarcoma Reaches Target Number of Progression-Free Survival Eventshttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=738327Wed, 06 Feb 2013 05:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=738327ZIOPHARM Oncology to Present at the 15th Annual BIO CEO & Investor Conferencehttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=731238Thu, 03 Jan 2013 05:00:00 GMThttp://ir.ziopharm.com/releasedetail.cfm?ReleaseID=731238ZIOPHARM Oncology to Present at the 31st Annual J.P. Morgan Healthcare Conference